Alpha-lipoic acid also plays a role in cellular energy metabolism and has been investigated for its potential therapeutic effects in CLD [62,63]
As GLP-1-based therapies reshape diabetes and obesity care, ongoing post-marketing safety monitoring will be essential to ensure that benefits continue to outweigh risks across diverse patient groups. She added future research may continue evaluating long-term and rare [GI] outcomes, particularly as these agents are increasingly prescribed for weight management in individuals without diabetes. For more information: Wajd Alkabbani, PhD, can be reached at [email protected].
Obwohl diese Medikamente seit fast zwei Jahrzehnten zur Behandlung von Typ-2-Diabetes eingesetzt werden, wurden sie erst 2021 von der US-amerikanischen FDA zur Behandlung von Adipositas zugelassen
How long before I see results with semaglutide
By catalyzing the carnitine/acylcarnitine exchange, CAC allows the import of fatty acyl moieties into the mitochondria where they are oxidized by the -oxidation pathway
Patients should seek urgent medical attention if they develop severe, persistent abdominal pain
